Search research articles
Contact Us
Filters
Showing results (141-150 of 189) with videos related to
Page
of 19
Sort By:
Journal of Immunological Methods
|
December 13, 2005
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
Mary L Disis, Corazon dela Rosa, Vivian Goodell, et al.
Gynecologic Oncology
|
January 17, 2017
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
John B Liao, Ron E Swensen, Kelsie J Ovenell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2016
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
Laura Q M Chow, Chihiro Morishima, Keith D Eaton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2016
Leveraging premalignant biology for immune-based cancer prevention
Avrum Spira, Mary L Disis, John T Schiller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2007
Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature
Margaret Inokuma, Corazon dela Rosa, Charles Schmitt, et al.
Evaluation & the Health Professions
|
September 26, 2013
Expanding assessments of translational research programs: supplementing metrics with value judgments
Craig S Scott, Pamela R Nagasawa, Neil F Abernethy, et al.
BMC Immunology
|
March 28, 2008
Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
Holden T Maecker, Jeffrey Hassler, Janice K Payne, et al.
Gynecologic Oncology
|
October 3, 2024
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer
John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, et al.
Cancer Research
|
June 19, 2008
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer
Kimberly R Kalli, Christopher J Krco, Lynn C Hartmann, et al.
Cancer Research
|
March 17, 2006
10th Biennial Helene Harris Memorial Trust meeting
Frances R Balkwill, Alan Ashworth, Robert C Bast, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 189) with videos related to
Sort By:
Page
of 19
Journal of Immunological Methods
|
December 13, 2005
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
Mary L Disis, Corazon dela Rosa, Vivian Goodell, et al.
Gynecologic Oncology
|
January 17, 2017
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
John B Liao, Ron E Swensen, Kelsie J Ovenell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2016
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
Laura Q M Chow, Chihiro Morishima, Keith D Eaton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2016
Leveraging premalignant biology for immune-based cancer prevention
Avrum Spira, Mary L Disis, John T Schiller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2007
Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature
Margaret Inokuma, Corazon dela Rosa, Charles Schmitt, et al.
Evaluation & the Health Professions
|
September 26, 2013
Expanding assessments of translational research programs: supplementing metrics with value judgments
Craig S Scott, Pamela R Nagasawa, Neil F Abernethy, et al.
BMC Immunology
|
March 28, 2008
Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides
Holden T Maecker, Jeffrey Hassler, Janice K Payne, et al.
Gynecologic Oncology
|
October 3, 2024
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer
John B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, et al.
Cancer Research
|
June 19, 2008
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer
Kimberly R Kalli, Christopher J Krco, Lynn C Hartmann, et al.
Cancer Research
|
March 17, 2006
10th Biennial Helene Harris Memorial Trust meeting
Frances R Balkwill, Alan Ashworth, Robert C Bast, et al.
Page
of 19